These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1793067)

  • 41. [PAF receptor antagonist in asthma therapy].
    Sagara H; Makino S; Fukuda T
    Nihon Rinsho; 1996 Nov; 54(11):3056-61. PubMed ID: 8950954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit.
    Lohman IC; Halonen M
    Am Rev Respir Dis; 1993 May; 147(5):1223-8. PubMed ID: 8484635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
    Foster AP; Cunningham FM; Andrews MJ; Lees P
    J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity.
    Mest HJ; Riedel A; Rein T
    Pharmacol Res; 1990; 22(4):445-53. PubMed ID: 2402478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of thromboxane A2 and platelet-activating factor in allergic bronchoconstriction in guinea pig airway in vivo.
    Saito M; Fujimura M; Ogawa H; Matsuda T
    J Lipid Mediat Cell Signal; 1995 Jan; 11(1):1-12. PubMed ID: 7728413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Agents Actions Suppl; 1990; 31():251-4. PubMed ID: 2080757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role for platelet-activating factor in asthma.
    Chung KF; Barnes PJ
    Lipids; 1991 Dec; 26(12):1277-9. PubMed ID: 1819715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RP 59227, a novel PAF receptor antagonist: effects in guinea pig models of airway hyperreactivity.
    Underwood SL; Lewis SA; Raeburn D
    Eur J Pharmacol; 1992 Jan; 210(1):97-102. PubMed ID: 1601051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
    Håkansson L; Venge P
    J Leukoc Biol; 1990 May; 47(5):449-56. PubMed ID: 2335754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PAF-acether and experimental anaphylaxis as a model for asthma.
    Pretolani M; Lellouch-Tubiana A; Lefort J; Bachelet M; Vargaftig BB
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):149-53. PubMed ID: 2540093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
    Vleeming W; Wemer J; Porsius AJ
    J Cardiovasc Pharmacol; 1992; 20(5):790-9. PubMed ID: 1280743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.
    Freitag A; Watson RM; Matsos G; Eastwood C; O'Byrne PM
    Thorax; 1993 Jun; 48(6):594-8. PubMed ID: 8346486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series.
    Weber KH; Heuer H
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):82-7. PubMed ID: 2540098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of PAF in postallergic propranolol-induced bronchoconstriction in guinea-pigs.
    Fujimura M; Tsujiura M; Songür N; Myou S; Matsuda T
    Eur Respir J; 1996 Oct; 9(10):2064-9. PubMed ID: 8902468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
    Desquand S; Lefort J; Dumarey C; Vargaftig BB
    Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles.
    Tool AT; Koenderman L; Kok PT; Blom M; Roos D; Verhoeven AJ
    Blood; 1992 May; 79(10):2729-32. PubMed ID: 1586719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor.
    Terasawa M; Aratani H; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):553-69. PubMed ID: 2093935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse.
    Henriques MG; Weg VB; Martins MA; Silva PM; Fernandes PD; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1990 Jan; 99(1):164-8. PubMed ID: 2331569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asthma as a chronic inflammatory disease and the implications for future therapy.
    Page C
    Ann Allergy; 1992 Sep; 69(3):251-60. PubMed ID: 1355953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.